Professional Summary
Professional Overview
Iris Ho-Palma is a seasoned finance executive with over 25 years of experience in driving strategic growth and operational excellence across various industries. As the Chief Financial Officer at ImmunoTek Plasma Bio Centers, she is responsible for overseeing the company's financial strategies, FP&A, and M&A initiatives to support its continued expansion and profitability.
Experience Summary
Current Role
As the Chief Financial Officer at ImmunoTek Plasma Bio Centers, Iris is responsible for leading the company's financial operations, including budgeting, forecasting, reporting, and risk management. She plays a pivotal role in developing and implementing financial strategies that align with the organization's long-term objectives, ensuring efficient resource allocation and optimizing financial performance.
Career Progression
Prior to her current role, Iris held the position of Chief Financial Officer at Petmate, where she successfully managed the company's financial operations and played a key role in driving strategic initiatives that led to improved profitability and market share. Before that, she served as the Vice President of Finance M&A, FP&A, and Field Finance at GameStop, where she contributed to the company's growth and transformation efforts.
Iris has also held leadership roles at NCH Corporation and Yum! Brands, where she demonstrated her expertise in international finance, mergers and acquisitions, and strategic planning. She began her career as a Senior Strategy Consultant at Bain & Company, where she honed her analytical and problem-solving skills.
Academic Background
Iris holds a Bachelor's degree in Business Administration from the University of California, Berkeley, and a Master's degree in Business Administration from the Harvard Business School.
Areas of Expertise
- Financial planning and analysis (FP&A)
- Strategic financial management
- Mergers and acquisitions (M&A)
- International finance and operations
- Performance optimization and cost management
- Risk management and compliance
Professional Impact
Throughout her career, Iris has consistently demonstrated her ability to drive financial and operational excellence. She has led successful M&A initiatives, implemented innovative financial strategies, and contributed to the growth and profitability of the organizations she has been a part of. Her expertise in international finance and operations has been instrumental in helping companies expand their global footprint and navigate complex regulatory environments.
Conclusion
With her extensive experience, strong leadership skills, and strategic mindset, Iris Ho-Palma is well-positioned to continue making a significant impact as the Chief Financial Officer at ImmunoTek Plasma Bio Centers. Her commitment to driving financial and operational excellence, coupled with her proven track record of success, makes her a valuable asset to the organization.
